Immunologic markers in the neonatal period: Diagnostic value and accuracy in infection

Expert Review of Molecular Diagnostics

Volumn 5, Issue 2, 2005, Pages 231-239

  Kafetzis, Dimitris A ^a   Tigani, Georgia S ^a   Costalos, Christos ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b ALEXANDRA HOSPITAL   (Greece)

Author keywords

C reactive protein; Cytokines; Diagnostic markers; Leukocyte cell surface antigens; Neonatal infection; Procalcitonin; Sepsis

Indexed keywords

C REACTIVE PROTEIN; CD11B ANTIGEN; CD64 ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 8; MEMBRANE ANTIGEN; PROCALCITONIN;

ANTIGEN EXPRESSION; BACTERIAL INFECTION; CELL MEMBRANE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE MARKER; FLOW CYTOMETRY; LEUKOCYTE ACTIVATION; NEWBORN INFECTION; NEWBORN PERIOD; REVIEW; SCREENING TEST;

ANTIGENS, CD11B; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CYTOKINES; FEMALE; FETAL DISEASES; HUMANS; PREGNANCY; RECEPTORS, IGG;

EID: 15444373423     PISSN: 14737159     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.5.2.231     Document Type: Review

References (90)

1. De Villiers WJ, Louw JP, Strachan AF et al. C-reactive protein and serum amyloid-A protein in pregnancy and labor. Br. J. Obstet. Gynecol. 97, 725-730 (1990).
2. Ainbender E, Cabatu EE, Guzman DM, Sweet AY. Serum C-reactive protein and problems of newborn infants. J. Pediatr. 101, 438-440 (1982).
3. Da Silva O, Ohlsson, Keynon C et al. Accuracy of leukocyte indices and C-reactive protein for diagnosis of neonatal sepsis. Pediatr. Infect. Dis. J. 14, 362-366 (1995).
4. Vigushin D, Pepys M, Hawkins P. Metabolic and scintigraphic studies of radioidinated human C-reactive protein in health and diseases. J. Clin. Invest. 91, 1351-1357 (1993).
5. Pourcyrous M, Bada HS, Korones SB et al. Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics 92, 431-435 (1993).
6. Chiesa C, Signore F, Assuma M et al. Serial measurements of C-reactive protein and interleukin-6 in the immediate postnatal period: Reference intervals and analysis of maternal and perinatal confounders. Clin. Chem. 47(6), 1016-1022 (2001). • Authors assess reference intervals for C-reacrive protein (CRP) and interleukin (IL)-6 during the 48-h period immediately after birth and identify maternal and perinatal factors that may affect them.
7. Ng PC, Cheng SH, Chui KM et al. Diagnosis of late-onset neonatal sepsis with cytokines, adhesion molecule and C-reactive protein in preterm very low birth-weight infants. Arch. Dis. Child. 77, F221-F227 (1997).
8. Benitz WE, Han MY, Madan A, Ramachandra P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 102, E41 (1998).
9. Mathers NJ, Pohlandt E. Diagnostc audit of C-reactive protein in neonatal infection. Eur. J. Pediatr. 146, 147-151 (1987).
10. Berger C, Uehlinger J, Ghelfi D, Blau N, Fanconi S. Comparison of C-reactive protein and white blood cell count with differential in neonates at risk for septicemia. Eur. J. Pediatr. 154, 138-144 (1995).
11. Wasunna A, Whitelaw A, Gallimore R, Hawkins PN, Pepys MB. C-reactive protein and bacterial infection in preterm infants. Eur. J. Pediatr. 149, 424-427 (1990).
12. Jaye D, Waites K. Clinical applications of C-reactive protein in pediatrics. Pediatr. Infect. Dis. J. 16(8), 735-747 (1997).
13. Philip AGS, Mills PC. Use of C-reactive protein in minimizing antibiotic exposure: experience with infants initially admitted to a well-baby nursery. Pediatrics 106, E4 (2000).
14. Kawamura M, Nishida H. The usefulness of serial C-reactive protein measurement in managing neonatal infection. Acta Paediatr. 84, 10-13 (1995).
15. Ishibashi M, Takemura Y, Ishida H et al. C-reactive protein kinetics in newborns: application of a high sensitive analytic method in its determination. Clin. Chem. 48(7), 1103-1106 (2002).
16. Dollner H, Arntzken K, Haereid PE et al. Interleukin-6 concentrations in neonates evaluated for sepsis. J. Pediatr. 132(2), 295-299 (1998).
17. Franz AR, Steinbach G, Kron M, Pohlandt F. Comparison of procalcitonin with Interleukin-8, C-reactive protein and differential white blood cell count for the early diagnosis of bacterial infections in newborn infants. Pediatr. Infect. Dis. J. 18, 666-671 (1999).
18. Franz AR, Steinbach G, Kron M, Pohlandt F. Reduction of unnecessary antibiotic therapy in newborn infants using Interleukin-8 and C-reactive protein as markers of bacterial infections. Pediatrics 104, 447-453 (1999).
19. Bomela H, Ballot D, Cory B, Cooper P. Use of C-reactive to guide duration of antibiotic therapy. In suspected early neonatal sepsis. Pediatr. Infect. Dis. J. 19, 531-535 (2000).
20. Alistair G, Mills P. Use of C-reactive protein in minimizing antibiotic exposure. Pediatrics 106(1), E4 (2000).
21. Santana C, Guindeo MC, González G et al. Cord blood levels of cytokines as predictors of early neonatal sepsis. Acta Paediatr. 90, 1176-1181 (2001). • Examines the diagnostic role of cytokine levels in umbilical cord blood and investigates whether the simultaneous assessment of CRP cord blood level can improve the diagnostic accuracy for early neonatal sepsis.
22. Yoon BH, Romero R, Shim JY et al. C-reactive protein in umbilical cord blood: a simple and widely available clinical method to assess the risk of amniotic fluid infection and funisitis. J. Matern. Fetal Med. 14(2), 85-90 (2003).
23. Berner R, Niemeyer CM, Leititis JU et al. Plasma levels and gene expression of granulocyte colony stimulating factor (GC-SF), tumor necrosis factor-α, interleukin-1β, interleukin-6, interleukin-8 and soluble intercellular adhesion molecule-1 in neonatal early-onset sepsis. Pediatr. Res. 44, 469-477 (1998).
24. Onal E, Kitapci F, Dilmen U et al. Interleukin-6 concentrations in neonatal sepsis. Lancet 353, 239-240 (1999).
25. Panero A, Pacifico L, RossI N et al. Interleukin-6 in neonates with early and late-onset infection. Pediatr. Infect. Dis. J. 16, 370-375 (1997).
26. Mehr S, Doyle LW. Cytokines as markers of bacterial sepsis in newborn infants: a review. Pediatr. Infect. Dis. J. 19, 879-887 (2000).
27. Kuster H, Weiss M, Willeitner AE et al. Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet 352, 1271-1277 (1998).
28. Silveira RC, Procianoy RS. Evaluation of interleukin-6, tumor necrosis factor-α and interleukin-1β for early diagnosis of neonatal sepsis. Acta Paediatr. 88, 647-650 (1999).
29. Mehr S, Doyle L. Interleukin-6 concentrations in neonatal sepsis. Lancet 353, 1798-1799 (1999).
30. Källman J, Ekholm L, Eriksson M, Malmström B, Schollin J. Contribution of interleukin-6 in distinguishing between mild respiratory disease and neonatal sepsis in the newborn infant. Acta Paediatr. 88, 880-884 (1999).
31. Laborada G, Rego M, Jain A et al. Diagnostic value of cytokines and C-reactive protein in the first 24 h of neonatal sepsis. Am. J. Perinatol. 20(8), 491-501 (2003).
32. Dollner H, Vatten L, Austgulen R. Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumor necrosis factor receptors and soluble adhesion molecules. J. Clin. Epidemiol. 54(12), 1251-1257 (2002).
33. Xanthou M, Fotopoulos S, Mouchtouri A et aL Inflammatory mediators in perinatal asphyxia and infection. Acta Paediatr. 438 (Suppl.), 92-97 (2002).
34. Yachie A, Takano N, Ohta K et al. Defective production of intrleukin-6 in very small premature infants in response to bacterial pathogens. Infect. Immun. 60, 749-753 (1992).
35. Weinmann E, Rutkowski S, Reisbach G. G-CSF and interleukin-6 in cord blood: Diminished increase of G-CSF and IL-6 in preterms with perinatal infection compared to term neonates. J. PeriNature Med. 26, 211-218 (1998).
36. De Jongh R, Puylaert M, Bosmans E et al. The fetomaternal dependency of cord blood interleukin-6. Am. J. Perinatol. 16, 121-128 (1999).
37. Perenyi A, Johann-Liang R, Stavola J. Assessment of cord blood IL-6 levels as an indicator of neonatal sepsis. Am. J. Perinatol. 16(10), 525-530 (1999).
38. Marchini G, Berggren V, Djilali-Merzoug R, Hansson LO. The birth process initiates an acute phase reaction in the fetus-newborn infant. Acta Paediatr. 89, 1082-1086 (2000).
39. Smulian JC, Vintzileos AM, Lai YL et al. Maternal chorioamnionitis and umbilical vein interleukin-6 levels for identifying early neonatal sepsis. J. Matern. Fetal Med. 8, 88-94 (1999).
40. Kashlan F, Smulian J, Anwar M et al. Umbilical vein interleukin-6 and tumor necrosis factor-α concentrations in the very preterm infant. Pediatr. Infect. Dis. J. 19, 238-243 (2000).
41. Dollner H, Vatten L, Linnebo I et al. Inflammatory mediators in umbilical plasma from neonates who develop early-onset sepsis. Biol. Neonate 80(1), 41-47 (2001).
42. Krueger M, Nauck MS, Saug S et al. Cord blood levels of interleukin-6 and interleukin-8 for the immediate diagnosis of early-onset infection in premature infants. Biol. Neonate 80(2), 118-123 (2001).
43. Buscher U, Chen FC, Pitzen A et al. IL-1β, IL-6, IL-8 and G-CSF in the diagnosis of early-onset neonatal infections. J. PeriNature Med. 28(5), 383-388 (2000).
44. Miller LC, Isa S, LoPreste G et al. Neonatal interleukin-1β, interleukin-6, and tumor necrosis factor: cord blood levels and cellular production. J. Pediatr. 117(6), 961-965 (1990).
45. Weeks JW, Reynold L, Taylor D et al. Umbilical cord blood interleukin-6 and neonatal morbidity. Obstet. Gynecol. 90, 815-818 (1997).
46. Rogers B, Alexander J, Head J et al. Umbilical vein interleukin-6 levels correlate with the severity of placental inflammation and gestational age. Human Pathol. 33(3), 335-340 (2002).
47. Mehr S, Doyle L, Rice G et al. Interleukin-6 and interleukin-8 in newborn bacterial infection. Am. J. Perinatol. 18, 313-323 (2001).
48. Nupponen I, Andersson S, Jävernpää A-L et al. Neutrophil CD11b expression and circulating interleukin-8 as diagnostic markers for early-onset neonatal sepsis. Pediatrics. 108, E12-E17 (2001). • Assesses the role of CD11b expression and circulating IL-8 and proposes these markers as sensitive diagnostic tests for early-onset neonatal sepsis.
49. Reyes SC, Garcia-Muñoz F, Reyes D et al. Role of cytokines (interleukin-1β, 6, 8, tumor necrosis factor-a and soluble receptor of interleukin-2) and C-reactive protein in the diagnosis of neonatal sepsis. Acta Paediatr. 92, 221-227 (2003). • Examines the role of cytokines in the diagnosis of neonatal sepsis and investigates whether their diagnostic power is enhanced when in combination with classic markers such as CRP and white blood cells.
50. Darbonne WC, Rice GC, Mohler MA et al. Red blood cells are a sink for interleukin-8, a leukocyte chemotaxin. J. Clin. Invest. 88, 1362-1369 (1991).
51. Reinsberg J, Dembinski J, Dorn C et al. Determination of total interleukin-8 in whole blood after cell lysis. Clin. Chem. 46, 1387-1394 (2000).
52. Orlikowsky TW, Neunhoeffer F, Goelz R et al. Evaluation of IL-8 concentration in plasma and lysed EDTA-blood in healthy neonates and those with suspected early onset bacterial infection. Pediatr. Res. 56(5), 804-809 (2004).
53. Al-Nawas B, Krammer I, Shah P. Procalcitonin in diagnosis of severe infections. Europ. J. Med. Res. 1, 331-333 (1996).
54. Chiesa D, Pacifico L, Mancuso G, Panero A. Procalcitonin in pediatrics: overview and challenge. Infection 26, 336-341 (1998).
55. Hatherill M, Tibby SM, Sykes K et al. Diagnostic markers of infection: comparison of procalcitonin with C-reactive protein and leukocyte count. Arch. Dis. Child. 81, 417-421 (1999).
56. Gendrel D, Raymond J, Coste J et al. Comparison of procalcitonin with C-reactive protein, interleukin-6 and interferon-α for differentiation of bacterial vs. viral infections. Pediatr. Infect. Dis. J. 18, 875-881 (1999).
57. Dandona P, Nix D, Wilson MF et al. Procalcitonin increase after endotoxin injection in normal subjects. J. Clin. Endocrinol. Metab. 79, 1605-1608 (1994).
58. Monneret G, Labaune JM, Isaac C et al. Procalcitonin and C-reactive protein levels in neonatal infections. Acta. Paediatr. 86, 209-212 (1997).
59. Chiesa C, Panero A, Rossi N et al. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin. Infect. Dis. 26, 664-672 (1998). • Investigates whether noninfectious neonatal and perinatal events alter procalcitonin (PCT) values, limiting the accuracy of the test, for the diagnosis of early-onset sepsis in critically ill neonates.
60. Guibourdenche J, Bedu A, Petzold L et al. Biochemical markers of neonatal sepsis: value of procalcitonin in the emergency setting. Ann. Clin. Biochem. 39, 130-135 (2002).
61. Resch B, Gusenleitner W, Müller WD. Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate. Acta Paediatr. 92, 243-245 (2003).
62. Distefano G, Curreri R, Betta P et al. Procalcitonin serum levels in perinatal bacterial and fungal infection of the preterm infants. Acta Paediatr. 93(2), 216-219 (2004).
63. Enguix A, Rey C, Concha A et al. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med. 27(1), 211-215 (2001).
64. Lapillone A, Basson E, Monneret G et al. Lack of specificity of procalcitonin for sepsis diagnosis inpremature infants. Lancet 351, 1211-1212 (1998).
65. Monneret G, Labaune JM, Isaac C et al. Increased serum procalcitonin levels are not specific to sepsis in neonates. Clin. Infect. Dis. 27, 1559-1560 (1998).
66. Chiesa C, Pellegrini G, Panero A et al. C-reactive protein, interleukin-6 and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications and infection. Clin. Chem. 49(1), 60-68 (2003). • Examines the influence of neonatal illness severity on CRP, IL-6 and PCT and gives useful information regarding the reliability of these markers in the immediate postnatal period.
67. Sachse C, Dressler F, Henkel E. Increased serum procalcitonin in newborn infants without infection. Clin. Chem. 44, 1343-1344 (1998).
68. Chiesa C, Panero A, Pacifico L. Increased serum procalcitonin levels are not specific to sepsis in neonates (Reply). Clin. Infect. Dis. J. 27, 1560 (1998).
69. Assuma M, Fabrizio S, Pacifico L et al. Serum procalcitonin concentrations in term delivering mothers and their healthy offspring: a longitudinal study. Clin. Chem. 46(10), 1583-1587 (2000). • Analyzes the postnatal course of PCT in healthy full-term neonates and provides information as to whether maternal or perinatal factors might affect the PCT value.
70. Sachse C, Dressler F, Henkel E. Usefulness of procalcitonin in neonates at risk for infection. Clin. Chem. 45, 441 (1999).
71. Richardson DK, Phibbs CS, Gray JE et al. Birth weight and illness severity: independent predictors of neonatal mortality. Pediatrics 91, 969-975 (1993).
72. Weirich E, Rabin RL, Maldonado Y et al. Neutrophil CD11b expression as a diagnostic marker for early-onset neonatal infection. J. Pediatr. 132, 445-451 (1998).
73. Fjaertoft G, Hakansson L, Ewald U et al. Neutrophils from term and preterm newborn infants express the high affinity Fcγ-receptor 1 (CD64) during bacterial infection. Pediatr. Res. 45, 871-876 (1999).
74. Ng PC, Li K, Wong RPO et al. Neutrophil CD64 expression: a sensitive diagnostic marker for late-onset nosocomial infection in very low birth-weight infants. Pediatr. Res. 51, 296-303 (2002). • Examines the role of neutrophil CD64 expression and proposes this marker as a sensitive diagnostic test for late-onset nosocomial infection in very low birthweight infants.
75. Ng PC. Diagnostic markers of infection in neonates (Review). Arch. Dis. Child. Fetal Neonatal Ed. 89, F229-F235 (2004).
76. Simms HH, D'Amico R. Lipopolysaccharide induces intracytoplasmic migration of polymorphonuclear leukocyte CD11b/CD18 receptor. Shock 3, 196-203 (1995).
77. Richardson DK, Gray JE, McCormick MC et al. Score for neonatal acute physiology: a physiologic severity index for neonatal intensive care. Pediatric. 91, 617-623 (1993).
78. Takala A, Jousela I, Jansson S-E et al. Markers of systemic inflammation predicting organ failure in community-acquired septic shock. Clin. Sci. (Colch). 97, 529-538 (1999).
79. Kaufman D, Kilpatrick L, Hudson G et al. Decreased superoxide production, degranulation, tumor necrosis factor α secretion, and CD11b/CD18 receptor expression by adherent monocytes from preterm infants. Clin. Diagn. Lab. Immunol. 6(4), 525-529 (1999).
80. Newman SL, Chaturvedi S, Klein BS. The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14. J. Immunol. 154, 753-761 (1995).
81. Takala A, Jousela I, Olkkola KT et al. Systemic inflammatory response syndrome without systemic inflammation in acutely ill patients admitted to hospital in a medical emergency. Clin. Sci. (Colch) 96, 287-295 (1999).
82. Weinschenk NP, Farina A, Branchi DW. Premature infants respond to early-onset and late-onset sepsis with leukocyte activation. J. Pediatr. 137, 345-350 (2000).
83. Sanchez-Mejorada G, Resales C. Signal transduction by immunological Fc receptors. J. Leukoc. Biol. 63, 521-533 (1998).
84. Leino L, Sorvajärvi K, Katajistos J et al. Febrile infection changes the expression of IgG Fc receptors and complement receptors in human neutrophils in vivo. Clin. Exp. Immunol. 107, 37-43 (1997).
85. Layseca-Espinosa E, Perez-Gonzales LF, Torres-Montes A et al. Expression of CD64 as a potential marker of neonatal sepsis. Pediatr. Allergy Immunol. 13(5), 319-327 (2002).
86. Ng PC, Li K, Chui KM et al. Neutrophil CD64 is a sensitive diagnostic marker for early-onset neonatal infection. Pediatr. Res. 56(5), 796-803 (2004).
87. Hodge S, Hodge G, Flower R, Han P. Surface activation of T-lymphocytes-role in the detection of infection in neonates. Clin. Exp. Immunol. 113, 33-38 (1998).
88. Hodge G, Hodge S, Han P, Haslam R. Multiple leukocyte activation markers to detect neonatal infection. Clin. Exp. Immunol. 135(1), 123-129 (2004).
89. Hodge G, Flower R, Han P. Optimal storage conditions for preserving granulocyte viability as monitored by Annexin V binding in whole blood. J. Immunol. Meth. 225, 27-38 (2000).
90. Hart S, Ross J, Haslett C, Dransfield I. Molecular characterization of the surface of apoptotic neutrophils: implications for functional downregulation and recognition by phagocytes. Cell Death Differ. 7, 493-503 (2003).